Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.01

-2.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J Stone who wrote (28917)	6/23/1999 1:45:00 AM
From: Cheryl Galt	Read Replies (2) of 32384

I've been checking every week for the 3-arm, Ph II Targretin Trial for ABC to show up in NCI's PDQ database. Saw it today for the first time. 26 centers are listed. cancernet.nci.nih.gov Phase II Randomized Study of Bexarotene (LGD1069) in Patients with Advanced Breast Cancer Protocol IDs: LIGAND-L1069-34, MSKCC-99008, UMN-9808M00110 Status: Active, New A total of 84-180 patients will be accrued for this study. ---------------------------------- Prior to this new PDQ entry, I saw it listed several months ago at the U of Virginia and Yale's web sites. I feel much more comfortable about accruals now that i see it in PDQ.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next